0000950170-24-068759.txt : 20240604
0000950170-24-068759.hdr.sgml : 20240604
20240604164209
ACCESSION NUMBER: 0000950170-24-068759
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240601
FILED AS OF DATE: 20240604
DATE AS OF CHANGE: 20240604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dunsire Deborah
CENTRAL INDEX KEY: 0001332764
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37813
FILM NUMBER: 241018854
MAIL ADDRESS:
STREET 1: C/O ULTRAGENYX PHARMACEUTICAL INC.
STREET 2: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Syros Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001556263
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 453772460
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 CAMBRIDGE PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: 617-744-1340
MAIL ADDRESS:
STREET 1: 35 CAMBRIDGE PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
FORMER COMPANY:
FORMER CONFORMED NAME: LS22, Inc.
DATE OF NAME CHANGE: 20120815
4
1
ownership.xml
4
X0508
4
2024-06-01
0001556263
Syros Pharmaceuticals, Inc.
SYRS
0001332764
Dunsire Deborah
C/O SYROS PHARMACEUTICALS, INC.
35 CAMBRIDGEPARK DRIVE
CAMBRIDGE
MA
02140
true
false
false
false
false
Common Stock
2024-06-01
4
M
false
4000
A
12000
D
Restricted Stock Units
2024-06-01
4
M
false
4000
0.00
D
Common Stock
4000
0
D
Represents shares of common stock received upon vesting of a restricted stock unit ("RSU") award.
Each RSU represents the contingent right to receive one share of the issuer's common stock.
These RSUs vested in their entirety on the first anniversary of the date of grant of the award.
/s/ Todd Rosenthal, as attorney-in-fact
2024-06-04